Fortgeschrittenes Nierenzellkarzinom: Nivolumab verlängert das Gesamtüberleben
Crossref DOI link: https://doi.org/10.1007/s00092-016-0946-8
Published Online: 2016-01-07
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Springer, Günter
Text and Data Mining valid from 2016-01-01
